- Advanced imaging and image-guided radiation therapy of head and neck malignancies
- Clinical trials of molecular targeted agents for head and neck cancer
- Radiation treatment planning and toxicity assessment
- Symptom assessment and supportive care
Int J Radiat Oncol Biol Phys. 2019 Sep 27;:
Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy.
Oral Oncol. 2019 Oct;97:124-130
Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Eur J Cancer. 2019 Jul 19;118:112-120
J Dent Res. 2019 Jul;98(8):879-887
Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.
Radiother Oncol. 2019 May;134:10-16
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys. 2019 Apr 04;:
Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy.
J Natl Cancer Inst. 2019 Mar 26;:
Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis.
Nat Commun. 2018 11 30;9(1):5116
18 F-FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta-analysis of reported studies.
Head Neck. 2018 Nov 20;:
Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Assistant Professor, Departments of Radiation Oncology and Otolaryngology, University of Toronto
Head and Neck Site Group Leader, Radiation Medicine Program, University Health Network
Vice President, University Health Network Medical Staff Association